Curative Biosciences, Inc. Stock

Equities

CBDX

US23127M1018

Pharmaceuticals

Market Closed - OTC Markets 01:12:25 2024-06-03 pm EDT 5-day change 1st Jan Change
0.0005 USD -66.67% Intraday chart for Curative Biosciences, Inc. 0.00% -66.67%
Current month-66.67%
1 month-66.67%
Sales 2016 - Sales 2017 - Capitalization 1.77M
Net income 2016 -1M Net income 2017 - EV / Sales 2016 -
Net Debt 2016 50.03K Net Debt 2017 62.83K EV / Sales 2017 -
P/E ratio 2016
-3.53 x
P/E ratio 2017
-33.2 x
Employees 6
Yield 2016 *
-
Yield 2017
-
Free-Float 70.57%
More Fundamentals * Assessed data
Dynamic Chart
1 day-66.67%
Current month-66.67%
1 month-66.67%
3 months-66.67%
6 months-66.67%
Current year-66.67%
More quotes
1 month
0.00
Extreme 0.0005
0.00
Current year
0.00
Extreme 0.0005
0.00
1 year
0.00
Extreme 0.0005
0.00
3 years
0.00
Extreme 0.0001
0.17
5 years
0.00
Extreme 0
0.50
10 years
0.00
Extreme 0
4.58
More quotes
Curative Biosciences, Inc., formerly Amaize Beverage Corporation, is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD (hemp derived Cannabidiol). The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The Company through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
More about the company